Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial

Clinical trial NCT01908465 · COMPLETED

Trial details

NCT number: NCT01908465
Sponsor: KU Leuven
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Irritable Bowel Syndrome (IBS)

Start date: 2013-11-01
Primary completion: 2022-11-02
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.